lobbying_activities: 1527575
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1527575 | 2403f9af-befb-43f2-aa95-e4e37bf37c09 | Q1 | GSK (FKA GLAXOSMITHKLINE INC.) | 16293 | GSK (FKA GLAXOSMITHKLINE INC.) | 2014 | first_quarter | CPT | H.R. 2582 - PATENT Jobs Act, provisions related to patent user fees H.R. 2605 - Manufacturing Innovation in America Act of 2013, provisions related to patent tax boxes H.R. 2639 - Patent Litigation and Innovation Act, patent litigation proposols H.R. 2766 - STOP Act, provisions related to business method patentsH.R. 3309 - Innovation Act, provisions related to patent litigation reform H.R. 3349 - Innovation Protection Act, provisions related to PTO fee diversion H.R. 3540 - Demand Letter Transparency Act H.R. 3709 - Protecting Consumer Access to Generic Drugs, provisions related to patent settlements H.R. 4287 - Independent Innovator and Repurposing Act, provisions related to patent term restoration S. 214 - The Preserve Access to Affordable Generics Act, provisions relating to patent settlements S. 504 - Fair and Immediate Release of Generic Drugs Act, provisions related to patent settlements S. 866 - Patent Quality Improvement Act of 2013, provisions related to business methods patents S. 1013 - Patent Abuse Reduction Act of 2013, provisions related to patent litigation reform S. 1612 - Patent Litigation Integrity Act, patent litigation provisions including bonding S. 1720 - Patent Transparency and Improvements Act S. 2049 - Transparency in Assertion of Patents Act, provisions related to patent demand letters S. 2150 - Independent Innovator and Repurposing Act, provisions related to patent term restoration S. 2196 - Patent Fee Integrity Act, patent fee diversion prohibition No bill # assigned - Biopharmaceutical innovation policy issues No bill # assigned - Biologics data protection issues No bill # assigned - Counterfeit drug issues | Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR) | 1630000 | 0 | 0 | 2014-04-18T14:11:03.963000-04:00 |